A detailed history of Price T Rowe Associates Inc transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,157,698 shares of IMCR stock, worth $61.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,157,698
Previous 2,832,669 23.83%
Holding current value
$61.8 Million
Previous $96 Million 30.03%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.06 - $41.49 $20.3 Million - $28 Million
-674,971 Reduced 23.83%
2,157,698 $67.2 Million
Q2 2024

Aug 14, 2024

BUY
$33.78 - $63.75 $13.3 Million - $25.2 Million
395,085 Added 16.21%
2,832,669 $96 Million
Q1 2024

May 15, 2024

SELL
$60.14 - $75.36 $30.5 Million - $38.2 Million
-506,990 Reduced 17.22%
2,437,584 $158 Million
Q4 2023

Feb 14, 2024

BUY
$42.85 - $69.5 $18.1 Million - $29.4 Million
423,290 Added 16.79%
2,944,574 $201 Million
Q3 2023

Nov 14, 2023

BUY
$49.5 - $66.6 $4.84 Million - $6.52 Million
97,864 Added 4.04%
2,521,284 $131 Million
Q2 2023

Aug 14, 2023

BUY
$48.54 - $61.64 $50.5 Million - $64.1 Million
1,039,980 Added 75.17%
2,423,420 $145 Million
Q1 2023

May 15, 2023

BUY
$46.12 - $65.71 $2.28 Million - $3.25 Million
49,524 Added 3.71%
1,383,440 $68.4 Million
Q4 2022

Feb 14, 2023

BUY
$45.51 - $65.08 $7.75 Million - $11.1 Million
170,355 Added 14.64%
1,333,916 $76.1 Million
Q3 2022

Nov 14, 2022

BUY
$37.34 - $57.44 $31.7 Million - $48.8 Million
849,662 Added 270.68%
1,163,561 $54.6 Million
Q2 2022

Aug 15, 2022

SELL
$25.46 - $37.72 $748,014 - $1.11 Million
-29,380 Reduced 8.56%
313,899 $11.7 Million
Q1 2022

May 16, 2022

SELL
$18.94 - $34.29 $693,431 - $1.26 Million
-36,612 Reduced 9.64%
343,279 $10.3 Million
Q4 2021

Feb 14, 2022

BUY
$27.58 - $40.0 $492,716 - $714,600
17,865 Added 4.93%
379,891 $13 Million
Q3 2021

Nov 15, 2021

SELL
$27.98 - $40.0 $147,678 - $211,120
-5,278 Reduced 1.44%
362,026 $13.4 Million
Q2 2021

Aug 16, 2021

SELL
$32.22 - $41.5 $663,989 - $855,232
-20,608 Reduced 5.31%
367,304 $14.3 Million
Q1 2021

May 17, 2021

BUY
$36.3 - $56.34 $14.1 Million - $21.9 Million
387,912 New
387,912 $16.5 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.26B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.